** Shares of Imricor Medical Systems IMR.AX rise 4.5% to A$1.525
** Stock rose as much as 7.2% to A$1.565 earlier in the day, its largest intraday pct gain since February 14
** The medical device developer narrows FY24 adjusted net loss to $15.6 million vs $16.7 million last year
** Also logs revenue $959,424 for fiscal 2024, up from $615,568 last year
** Says revenue growth driven by capital sales and new site activations
** More than 258,000 shares change hands vs 30-day avg volume of 236,000 shares
** Stock up 13.2% YTD, including current session's moves
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。